Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations - PubMed
Comparative Study
. 2004 Mar;114(4):354-65.
doi: 10.1007/s00439-003-1073-7. Epub 2004 Jan 22.
Affiliations
- PMID: 14740294
- DOI: 10.1007/s00439-003-1073-7
Comparative Study
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations
Doron M Behar et al. Hum Genet. 2004 Mar.
Abstract
The molecular basis of more than 25 genetic diseases has been described in Ashkenazi Jewish populations. Most of these diseases are characterized by one or two major founder mutations that are present in the Ashkenazi population at elevated frequencies. One explanation for this preponderance of recessive diseases is accentuated genetic drift resulting from a series of dispersals to and within Europe, endogamy, and/or recent rapid population growth. However, a clear picture of the manner in which neutral genetic variation has been affected by such a demographic history has not yet emerged. We have examined a set of 32 binary markers (single nucleotide polymorphisms; SNPs) and 10 microsatellites on the non-recombining portion of the Y chromosome (NRY) to investigate the ways in which patterns of variation differ between Ashkenazi Jewish and their non-Jewish host populations in Europe. This set of SNPs defines a total of 20 NRY haplogroups in these populations, at least four of which are likely to have been part of the ancestral Ashkenazi gene pool in the Near East, and at least three of which may have introgressed to some degree into Ashkenazi populations after their dispersal to Europe. It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability, especially in those founder haplogroups that migrated from the Near East. This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity.
Similar articles
-
Mendez FL, Karafet TM, Krahn T, Ostrer H, Soodyall H, Hammer MF. Mendez FL, et al. Hum Biol. 2011 Feb;83(1):39-53. doi: 10.3378/027.083.0103. Hum Biol. 2011. PMID: 21453003
-
No evidence from genome-wide data of a Khazar origin for the Ashkenazi Jews.
Behar DM, Metspalu M, Baran Y, Kopelman NM, Yunusbayev B, Gladstein A, Tzur S, Sahakyan H, Bahmanimehr A, Yepiskoposyan L, Tambets K, Khusnutdinova EK, Kushniarevich A, Balanovsky O, Balanovsky E, Kovacevic L, Marjanovic D, Mihailov E, Kouvatsi A, Triantaphyllidis C, King RJ, Semino O, Torroni A, Hammer MF, Metspalu E, Skorecki K, Rosset S, Halperin E, Villems R, Rosenberg NA. Behar DM, et al. Hum Biol. 2013 Dec;85(6):859-900. doi: 10.3378/027.085.0604. Hum Biol. 2013. PMID: 25079123
-
MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population.
Behar DM, Hammer MF, Garrigan D, Villems R, Bonne-Tamir B, Richards M, Gurwitz D, Rosengarten D, Kaplan M, Della Pergola S, Quintana-Murci L, Skorecki K. Behar DM, et al. Eur J Hum Genet. 2004 May;12(5):355-64. doi: 10.1038/sj.ejhg.5201156. Eur J Hum Genet. 2004. PMID: 14722586
-
Karafet TM, Osipova LP, Gubina MA, Posukh OL, Zegura SL, Hammer MF. Karafet TM, et al. Hum Biol. 2002 Dec;74(6):761-89. doi: 10.1353/hub.2003.0006. Hum Biol. 2002. PMID: 12617488 Review.
-
Cystic fibrosis in Jews: frequency and mutation distribution.
Kerem B, Chiba-Falek O, Kerem E. Kerem B, et al. Genet Test. 1997;1(1):35-9. doi: 10.1089/gte.1997.1.35. Genet Test. 1997. PMID: 10464623 Review.
Cited by
-
Ancient DNA reveals male diffusion through the Neolithic Mediterranean route.
Lacan M, Keyser C, Ricaut FX, Brucato N, Duranthon F, Guilaine J, Crubézy E, Ludes B. Lacan M, et al. Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9788-91. doi: 10.1073/pnas.1100723108. Epub 2011 May 31. Proc Natl Acad Sci U S A. 2011. PMID: 21628562 Free PMC article.
-
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.
Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, Chowers Y, Clark LN, Darvasi A, Doheny D, Duerr RH, Eliakim R, Giladi N, Gregersen PK, Hakonarson H, Jones MR, Marder K, McGovern DP, Mulle J, Orr-Urtreger A, Proctor DD, Pulver A, Rotter JI, Silverberg MS, Ullman T, Warren ST, Waterman M, Zhang W, Bergman A, Mayer L, Katz S, Desnick RJ, Cho JH, Peter I. Kenny EE, et al. PLoS Genet. 2012;8(3):e1002559. doi: 10.1371/journal.pgen.1002559. Epub 2012 Mar 8. PLoS Genet. 2012. PMID: 22412388 Free PMC article.
-
Szécsényi-Nagy A, Brandt G, Haak W, Keerl V, Jakucs J, Möller-Rieker S, Köhler K, Mende BG, Oross K, Marton T, Osztás A, Kiss V, Fecher M, Pálfi G, Molnár E, Sebők K, Czene A, Paluch T, Šlaus M, Novak M, Pećina-Šlaus N, Ősz B, Voicsek V, Somogyi K, Tóth G, Kromer B, Bánffy E, Alt KW. Szécsényi-Nagy A, et al. Proc Biol Sci. 2015 Apr 22;282(1805):20150339. doi: 10.1098/rspb.2015.0339. Proc Biol Sci. 2015. PMID: 25808890 Free PMC article.
-
Tofanelli S, Taglioli L, Bertoncini S, Francalacci P, Klyosov A, Pagani L. Tofanelli S, et al. Front Genet. 2014 Nov 10;5:384. doi: 10.3389/fgene.2014.00384. eCollection 2014. Front Genet. 2014. PMID: 25431579 Free PMC article.
-
Afghanistan from a Y-chromosome perspective.
Lacau H, Gayden T, Regueiro M, Chennakrishnaiah S, Bukhari A, Underhill PA, Garcia-Bertrand RL, Herrera RJ. Lacau H, et al. Eur J Hum Genet. 2012 Oct;20(10):1063-70. doi: 10.1038/ejhg.2012.59. Epub 2012 Apr 18. Eur J Hum Genet. 2012. PMID: 22510847 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources